Michael Gordon - Division of Cancer Research, HonorHealth Research Institute

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Data from Cooperative Dynamics of AR and ER Activity in Breast Cancer

Nicholas C. D'Amato,Michael A. Gordon,Beatrice Babbs,Nicole S. Spoelstra,Kiel T. Carson Butterfield,Kathleen C. Torkko,Vernon T. Phan,Valerie N. Barton,Thomas J. Rogers,Carol A. Sartorius,Anthony Elias,Jason Gertz,Britta M. Jacobsen,Jennifer K. Richer

crossref（2023）

引用0浏览0引用

Supplementary Methods from Cooperative Dynamics of AR and ER Activity in Breast Cancer

crossref（2023）

引用0浏览0引用

Supplemental Figure Legends from A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer

Nicholas C. D'Amato,Thomas J. Rogers,Michael A. Gordon,Lisa I. Greene,Dawn R. Cochrane,Nicole S. Spoelstra,Travis G. Nemkov,Angelo D'Alessandro,Kirk C. Hansen,Jennifer K. Richer

crossref（2023）

引用0浏览0引用

Supplementary Figures 1-6 from Cooperative Dynamics of AR and ER Activity in Breast Cancer

crossref（2023）

引用0浏览0引用

Supplemental Figures S1-S7 from A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer

Nicholas C. D'Amato,Thomas J. Rogers,Michael A. Gordon,Lisa I. Greene,Dawn R. Cochrane,Nicole S. Spoelstra,Travis G. Nemkov,Angelo D'Alessandro,Kirk C. Hansen,Jennifer K. Richer

openalex（2023）

引用0浏览0引用

Supplementary Figure Legends from Cooperative Dynamics of AR and ER Activity in Breast Cancer

crossref（2023）

引用0浏览0引用

LBA-4 Results from an Expanded Phase 1 Trial of Botensilimab (BOT), a Multifunctional Anti-Ctla-4, Plus Balstilimab (BAL; Anti-Pd-1) for Metastatic Heavily Pretreated Microsatellite Stable Colorectal Cancer (MSS CRC)

A. Bullock,M. Fakih,M. Gordon,A. Tsimberidou,A. El-Khoueiry,B. Wilky, A. Pimentel, K. Margolin, D. Mahadevan,A. Balmanoukian,R. Sanborn,G. Schwartz,G. Abou-Alfa,B. Bockorny,J. Moser, S. Sharma,J. Grossman, K. Rosenthal,S. O'Day,H. Lenz, B. Schlechter

Annals of oncology（2023）

引用1浏览0引用

Supplementary Figure 1 from Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer

Johanna C. Bendell,Michael S. Gordon,Herbert I. Hurwitz,Suzanne F. Jones,David S. Mendelson,Gerard C. Blobe,Neeraj Agarwal,Carolyn H. Condon,Dawn Wilson,Amelia E. Pearsall,Yijun Yang,Ty McClure,Kenneth M. Attie,Matthew L. Sherman, Sunil Sharma

crossref（2023）

引用0浏览0引用

Supplementary Figure 2 from Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer

crossref（2023）

引用0浏览0引用

756 First-in-human, Open-Label, Multicenter, Phase 1 Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti Siglec-15 PYX-106 in Subjects with Advanced Solid Tumors

Bin Zhang,Marsha Crochiere,Anthony W Tolcher,Randy Sweis,Kartik Sehgal,Michael S Gordon,Shui He,Jason Henry,Alexander I Spira,Shiraj Sen,Sandip P Patel, Sondra Smyrnios, Dipali Unadkat

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn